• Release date: June 13, 2014
  • Expiration date: June 12, 2015
  • Estimated time to complete activity: 1 hour. 
  • Please click the following link to confirm: http://pcna.peachnewmedia.com/SystemCheckv2/
  • Jointly sponsored/Co-provided by Postgraduate Institute for Medicine, PCNA, and CE Health Interactive
  • This activity is supported by an educational grant from AstraZeneca

Target Audience

This activity has been designed to meet the educational needs of physicians, advanced practice nurses and nurses who work in acute cardiac care settings, ambulatory cardiology practices, cardiac rehabilitation, case management, and primary care, as well as other specialists including cardiologists, primary care clinicians, hospitalists, intensivists, and emergency medicine specialists, involved in the management of patients with acute coronary syndrome (ACS).


Statement of Need/Program Overview


Adherence to professional guidelines by healthcare professionals in the management of patients with acute coronary syndrome (ACS) remains suboptimal despite the fact that the implementation of professional guidelines into treatment strategies has been shown to improve outcomes in patients with ACS post-hospitalization. In addition, patient adherence to therapy is also suboptimal. Clinicians can improve patient adherence by learning about patient-related factors of nonadherence to therapy and addressing those factors with their patients. Several methods for effectively addressing patient- and provider-related barriers to adherence that support long-term treatment goals through improved adherence rates have been developed. Advancements in antiplatelet therapy that are aimed at increasing adherence through improved efficacy and safety profiles continue; however, several barriers to their use and implementation exist, including the volume of information available to clinicians. Barriers to the effective use of these agents is multi-layered and requires educational initiatives to provide healthcare practitioners with a working knowledge of the agents available, as well as those on the horizon, so that guideline adherence and the use of effective agents can increase, thereby improving patient outcomes.

 

Educational Objectives


After completing this activity, the participant should be better able to:

  • Objective #1: Implement evidence-based options recommended in professional guidelines for antithrombotic therapy in ACS patients.
  • Objective #2: Use achieved knowledge of antithrombotic options to manage ACS patients post-hospitalization.
  • Objective #3: Identify issues involving communication gaps between patient advocates and patients diagnosed with ACS.
  • Objective #4: Apply practical solutions for improving communications to effectively counsel ACS patients on medication access, the importance of long term persistence with therapy, and local pharmacy communications. 

Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and CE Health Interactive. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. 

Nurses – How to Claim Credit
Nurse and nurse practitioner learners will view the course materials; complete the post-test (post-test can be taken more than once to achieve a passing score of 75%); the CE evaluation and may then print the CE certificate.


Physicians – How to Claim Credit
Please go online to CME University at: www.cmeuniversity.com, and register or login (takes less than 1 minute).
Once logged in, follow these steps:
  • Click on the “Find Post-Test/Evaluation by Course:” at the top of the page.
  • Type in “9669” and hit enter.
  • Click on the activity title when it appears.
  • Choose your profession/type of credit you are seeking.
  • Complete the online posttest and Evaluation Form.
Upon successful completion of the posttest, 70% or better, and the online Evaluation form, you will have immediate access to a certificate of attendance to print or save for your files.
If you have any questions regarding the CME certification for this activity, please contact Postgraduate Institute for Medicine at: information@pimed.com or (303) 799-1930.

Introduction
 

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

 

Name of Faculty or Presenter

Reported Financial Relationship

Peter B. Berger, MD, FACC

No conflicts of interest to report

Lynne T. Braun PhD, CNP, CLS, FAHA, FPCNA, FAAN

Advisory Boards/Consultant: Sanofi

Speakers Bureau: Practice Point

Judith Schipper, MS, NP-C, CLS, FNLA, FPCNA

No conflicts of interest to report

 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

 

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

 

James A. Shiffer, RPh, Medical Director, CE Health Interactive hereby states that he does not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

 

Suzanne Hughes, MSN, RN, CNS, Clinical Education Project Director, PCNA, hereby states that she does not currently, or within the past 2 years, have any financial relationships related to the content of this presentation.


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  


The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


 

Lynne Braun
Speaker Information
Lynne Braun, PhD, CNP, FAHA, FAAN   [ view bio ]
Judith Schipper
Speaker Information
Judith Schipper, MS, NP-C, CLS, CHFN, FNLA, FPCNA   [ view bio ]
Peter Berger
Speaker Information
Peter B. Berger, MD, FACC   [ view bio ]
Closing and Post-test
Individual topic purchase: Selected

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.


ACCREDITOR:

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. 

 

Preventive Cardiovascular Nurses Association
Contact Hour Total: 0.80
Total Hour: 0.80
Products
Patient Advocacy in Post-Hospitalization Care of ACS: Closing Communication Gaps and Engaging Patients
This seminar is presented free of charge.